Strategic investors are increasingly interested in getting into startups early says Alexa von Tobel, co-founder and managing ...

Balchem reported Q3 2026 sales of $290.7 million, up 8.6%, while net earnings rose 16% to $46.7 million and adjusted EBITDA ...

Zymeworks signs a Roche licensing deal worth up to $813 million for ZW209, including $55 million upfront and potential ...

American Express Q3 2026 net income rose to $3.7 billion and EPS increased 31% to $5.42 as the company raised its full-year ...

Booz Allen Hamilton reported adjusted EPS of $1.76 in fiscal Q2 2027, beating estimates, while revenue reached $2.78 billion ...

Evaxion reports sustained three-year responses in its Phase 2 EVX-01 melanoma trial, with 89% T-cell target recognition and ...

Rithm Capital reported Q3 2026 net income of $217.1 million, distributable earnings of $315.3 million and a quarterly common ...

Bristol Myers Squibb shares fell 2.4% to $61.47 after disclosure of a fatal septic pneumonia event following the data cutoff ...

Rogers Communications Q3 2026 revenue rose 2% to C$5.443 billion, free cash flow increased 65%, and the company completed its ...

Zai Lab reported an 81.8% response rate for zoci plus atezolizumab in a Phase 1b small cell lung cancer trial and plans a ...

First Citizens Q3 2026 net income fell to $606 million despite loan and deposit growth, as the bank approved an additional $1 ...

Bloomberg's Lisa Mateo, Scarlet Fu, and Tom Keene discuss the release of the new Apple iPhone on this weeks edition of ...